Treatment Cycle: 30 days Timing of dose: Take capsule with food, preferably early in the day
Personally, I use my upper buttocks region Supplies 23-25 gauge needle, 1- 1 length Your healthcare professional will instruct per your body type and injection location
Standalone GHK-Cu works for focused studies
Real patients should see it available in pharmacies by early-to-mid 2027
Cagrilintide vs tirzepatide (Mounjaro/Zepbound) Mechanism: Cagrilintide: Amylin agonist Tirzepatide: Dual GIP/GLP-1 agonist Both novel approaches Weight loss: Cagrilintide: 10-12% monotherapy Tirzepatide: 15-22% monotherapy Tirzepatide superior as single agent Administration: Both: Weekly subcutaneous injection Both: Similar convenience Side effects: Cagrilintide: Strong GI effects Tirzepatide: Moderate GI effects Similar overall profile Approval status: Cagrilintide: Investigational Tirzepatide: FDA approved Tirzepatide available now Cost (when both available): Likely similar ($1,000-1,500/month) Both premium weight loss options Verdict: Currently, tirzepatide better choice (approved, superior weight loss)
These individuals may need much higher doses or may not see the same results as they would with injections
